The price represents a 64% premium to Bioverativ stock’s close on Friday on the Nasdaq. Bioverativ, a hemophilia drug maker, was separated from Biogen Inc early last year. Sanofi has failed to land major deals after losing California …
Sanofi broke its 2011 merger agreement with Genzyme Corp. by failing to use "diligent efforts" to win regulatory approval and reach sales targets for the drug Lemtrada, the trustee, American Stock Transfer & Trust Co., said in a complaint …
MannKind said Tuesday its licensing agreement with French drug giant Sanofi has ended, sending the Danbury drug manufacturer’s stock below $1 and sparking concern among some analysts that the company may face bankruptcy …
But investors were not convinced, sending Sanofi's shares sharply lower in early business on the Paris stock exchange as they wondered about the wisdom of putting so much money on the table. The deal "looks logical, but expensive", with …
Sanofi's (SANL) 3QCY17 revenue increased ~7% YoY (+11% QoQ) to INR6.7b (~3.4% miss). EBITDA rose 27% YoY to INR1.8b (+21% beat), as margins expanded ~440bp YoY (+830bp QoQ) to 27.5%. Consequently, PAT increased …
Rajaram joined Sanofi in February 2014 and was appointed whole-time director in October 2015, the company said in a statement. He was managing director for over 12 years and will also continue as a non-executive director on the board. …
A survey by the Independent Pharmacy Federation has identified Eli Lily, Pfizer and Sanofi as the drugmakers that present them with the worst difficulties in obtaining medicine supplies. Out of more than 500 independent pharmacists …
The price rallied off the low, erasing all the losses from the most recent down wave (February). Since hitting a swing high of $39.04 on March 22, the stock has pulled back, closing at $37.25 on March 29. The slowed momentum to the …
Shares of Medivation Inc (NASDAQ: MDVN) were trading up more than 11 percent in Tuesday's after-hours session, driven by a report about a "rebuffed takeover approach" from Sanofi SA (ADR ... the after-hours session. The stock traded …